This retrospective case–control study aimed to assess the relationship between first‑trimester glycolipid metabolism and inflammatory markers and the subsequent risk of gestational diabetes mellitus (GDM). The investigators also examined potential interactive effects between glycolipid markers, inflammatory factors, and maternal characteristics on GDM development.
The analysis used electronic medical records from Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, a primary and comprehensive hospital serving a rural district of Shanghai. Records reviewed were from the 2019 calendar year.
Women were eligible if they were registered Shanghai residents who planned to remain in Shanghai for at least 2 years, had their first prenatal visit before 20 weeks’ gestation, planned to deliver at Zhoupu Hospital, and had complete medical history, laboratory data, and regular prenatal visits (≥6) documented before delivery.
Exclusion criteria were preexisting type 1 or type 2 diabetes mellitus, chronic hypertension, prior drug treatment for dyslipidaemia, cardiovascular disease, or other illnesses that contraindicate pregnancy.
Investigators retrospectively screened electronic health records for 2,255 pregnant women seen at the hospital in 2019. After applying eligibility criteria and verifying completeness of records, 678 women were included in the final analysis. Among these, 133 women were diagnosed with GDM and 545 had normal glucose tolerance.
The study evaluated markers of glycolipid metabolism and systemic inflammation measured in early pregnancy. Key variables highlighted in the report include C‑reactive protein (CRP), triglycerides (TG), lymphocyte count, and glycated haemoglobin (HbA1c). These measures were considered as predictors of later GDM diagnosis.
The investigators report that higher early‑pregnancy levels of CRP, TG, lymphocyte count, and HbA1c were each associated with an increased risk of developing GDM in this cohort. The study further suggests that these glycolipid and inflammatory indicators observed in the first trimester may be useful signals of elevated GDM risk.
Note: The source summary does not provide detailed numerical results, such as odds ratios, confidence intervals, or exact p‑values for the associations. Those detailed statistics were not reported in the provided source text and therefore are not included here.
Beyond individual marker associations, the study reports interactions among CRP, TG, lymphocyte count, HbA1c, and maternal characteristics including age and body mass index (BMI). The authors suggest that combinations of altered inflammatory and glycolipid markers together with older maternal age or higher BMI may contribute to the development of GDM.
The summary provided does not include the specific interaction estimates, the statistical methods used to test interaction, or stratified results. Those methodological and quantitative details were not reported in the available source material.
This summary is limited to the information reported in the source abstract and related highlights. The source did not report precise effect sizes, confidence intervals, detailed adjustment covariates, or full statistical testing results for main effects and interactions. Information on the timing of laboratory measurements within the first trimester, assay methods, or thresholds used for marker categorization was not provided in the source text.
Because the analysis was retrospective and derived from a single hospital’s electronic records in one rural district, the authors note the need for external validation in larger and more diverse cohorts before generalizing these findings.
In this rural Shanghai population, elevated glycolipid markers and altered inflammatory indicators measured in early pregnancy were associated with higher risk of GDM. Reported interactions with maternal age and BMI suggest that combined metabolic and inflammatory changes plus traditional risk factors may jointly influence GDM development. The authors recommend external validation studies in larger, more diverse populations to confirm these associations and to inform potential early‑pregnancy risk stratification strategies.